Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-announces-U-S-FDA-Orphan-Drug-Designation-granted-to-lisavanbulin-for-the-treatment-of-mali-35996916/?utm_source=whatsapp&utm_medium=social&utm_campaign=share